(S1 (S (S (NP (JJ VEGF-targeted) (NN therapy)) (: :) (NP (NP (JJ therapeutic) (NN potential)) (CC and) (NP (JJ recent) (NNS advances)))) (. .)))
(S1 (S (S (PP (IN After) (NP (NP (QP (IN over) (CD 30)) (NNS years)) (PP (IN of) (NP (NN theorizing))))) (, ,) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NN angiogenesis) (NNS inhibitors))) (PP (IN as) (NP (NN anticancer) (NN therapy)))) (VP (VBZ has) (VP (ADVP (RB finally)) (VBN moved) (PP (IN from) (NP (NP (DT the) (NN realm)) (PP (IN of) (NP (NN research))))) (PP (TO to) (NP (NN reality)))))) (. .)))
(S1 (S (S (NP (JJ Normal) (JJ adult) (NN vasculature)) (VP (VBZ is) (ADJP (RB generally) (JJ quiescent) (PP (IN in) (NP (NN nature)))) (, ,) (PP (IN with) (NP (NP (JJ endothelial) (NNS cells)) (VP (VBG dividing) (NP (QP (RB approximately) (DT every) (CD 10)) (NNS years))))))) (. .)))
(S1 (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (DT the) (NN growth)) (PP (IN of) (NP (NNS tumors)))) (VP (VBZ requires) (NP (NP (JJ constant) (JJ vascular) (NP (NP (NN growth)) (CC and) (NP (NN remodeling)))) (PP (IN in) (NP (NP (NN order)) (PP (IN for) (NP (JJ solid) (NNS tumors)))))) (S (VP (TO to) (VP (VB grow) (PP (IN beyond) (NP (NP (CD 1-2) (NN mm-LRB-3-RRB-)) (PP (IN in) (NP (NN size))))))))) (. .)))
(S1 (S (S (NP (NP (NP (JJ Vascular) (JJ endothelial) (NN growth) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN VEGF)) (-RRB- -RRB-))) (CC and) (NP (PRP$ its) (NNS receptors))) (VP (VBP are) (NP (NP (JJ key) (NNS regulators)) (PP (IN of) (NP (NP (DT the) (NN process)) (PP (IN of) (NP (NN angiogenesis))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ makes) (S (NP (PRP them)) (VP (JJ attractive) (NP (JJ therapeutic) (NNS targets)))))))))) (. .)))
(S1 (S (S (NP (NP (DT A) (NN multitude)) (PP (IN of) (NP (JJ VEGF-targeted) (JJ inhibitory) (NNS agents)))) (VP (VBP are) (ADVP (RB currently)) (VP (VBG being) (VP (VBN investigated) (PP (IN for) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NN cancer))))))))) (. .)))
(S1 (S (S (NP (DT This) (NN review) (NN article)) (VP (VBZ focuses) (PP (IN on) (NP (NP (JJ recent) (NNS developments)) (PP (IN in) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NN angiogenesis) (NNS inhibitors))) (PP (IN for) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NP (NN breast)) (, ,) (NP (NN lung)) (, ,) (CC and) (NP (JJ colorectal) (NNS cancers)))))))))))) (. .)))
